Location

San Francisco Marriott Marquis, Yerba Buena Salon 3-6
780 Mission Street, San Francisco, CA.

Date & Time

Wednesday, May 7, 2014 • 11:00AM-1:00PM

Activity Description

This educational lunch symposium has been designed to enhance clinical knowledge surrounding left atrial appendage exclusion for stroke prophylaxis in AF patients, its role as an adjunctive therapy to AF treatment, and current catheter ablation approaches to persistent AF.

In the first session, participants will review embryology and anatomy of LAA, as well as stroke and bleeding risks in patients with AF, and examine significant LAA closure data. Next, attendees will observe best practices in patient selection, and optimal LAA exclusion procedural approaches through a review of study data, along with expert clinical experiences. The third session will explore current catheter ablation approaches to persistent AF, and consider the impact sinus rhythm maintenance has for reducing cardioembolic stroke. The final session will analyze the role of LAA exclusion as adjunctive therapy to AF treatment, concluding with panel discussions and an engaging Q&A session.

Activity Goal

This activity is designed to address the following ABMS/IOM competencies: Patient Care, Medical Knowledge, and Practice-Based Learning.

Faculty

Dhanunjaya Lakkireddy, MD, FACC, FHRS
Director, Center for Excellence in Atrial Fibrillation & Electrophysiology Research Professor of Medicine,
University of Kansas Medical Center and Hospital
Governor Elect Kansas ACC Chapter
Kansas City, KS

Randall Lee, MD, PhD
Professor of Medicine, Division of Cardiology
University California San Francisco
San Francisco, CA

Abdi Rasekh, MD, FACC
Department of Cardiology
Texas Heart Institute at St. Luke’s Episcopal Hospital
Houston, TX

David Wilber, MD, FAHA, FACC, FHRS
George M. Eisenberg Professor of Cardiovascular Sciences
Director, Division of Cardiology and the Cardiovascular Institute
Director, Clinical Electrophysiology
Loyola University Medical Center
Maywood, IL

Agenda

11:00AM-11:30AM	Registration
11:30AM	Lunch Seating
11:35AM-11:40AM	Welcome and Opening Remarks David Wilber, MD, FAHA, FACC, FHRS
11:40AM-11:55AM	Why does LAA Exclusion make sense? Dhanunjaya Lakkireddy, MD, FACC, FHRS
11:55AM-12:10PM	Emerging LAA Exclusion Techniques and Technologies Abdi Rasekh, MD, FACC
12:10PM-12:25PM	Current Catheter Ablation Approaches to Persistent AF: Does maintenance of Sinus Rhythm reduce Cardioembolic events? David Wilber, MD, FAHA, FACC, FHRS
12:25PM-12:40PM	Role of LAA Exclusion as Adjunctive Therapy to AF treatment Randall Lee, MD, PhD
12:40PM-1:00PM	Panel Discussion with Q&A Session

Target Audience

This activity has been developed to meet the educational needs of electrophysiologists, cardiologists and other physicians and associated professionals who are dedicated to managing patients with Atrial Fibrillation.

Learning Objectives

Upon completion of this educational activity, participants will be able to:

• Evaluate embryology and anatomy of the left atrial appendage, and assess thrombus formation in the LAA.
• Discuss clinical trial data in LAA exclusion and investigate optimal patient selection strategies to identify candidates for interventional therapy.
• Review current catheter ablation approaches for persistent AF, and discuss the impact of sinus rhythm maintenance for reducing cardioembolic events.
• Consider the role of LAA exclusion as adjunctive therapy for AF ablation.

Commercial Support

This activity is supported by an educational grant from

 

Sponsor

     

Accreditation Statement

This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education through joint sponsorship of MediaSphere Medical, LLC and Cine-Med. Cine-Med is accredited by the ACCME to provide continuing medical education for physicians.

Cine-Med designates this educational activity for a maximum of 1.5 AMA PRA CATEGORY 1 Credits(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

MediaSphere Medical designates this educational activity for 1.5 Contact Hours. MediaSphere Medical is approved by the California Board of Registered Nursing, Provider Number 15880.

Disclosure Policy

It is the policy of MediaSphere Medical and Cine-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months.

MediaSphere Medical and Cine-Med implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners. Faculty disclosures will be made available on the course syllabus book and faculty introductory slides.

“This program is not part of the Heart Rhythm 2014 Official Scientific Sessions as planned by the Heart Rhythm Society Scientific Sessions Program Committee. This event is neither sponsored nor endorsed by the Heart Rhythm Society”